CTOs on the Move

NeuBase Therapeutics

www.neubasetherapeutics.com

 
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Anthony Rossomando
 Chief Technology Officer Profile

Similar Companies

DK Sinopharma

DK Sinopharma is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Applied Medical

Applied Medical - Corporate Site

Essential Formulas

Essential Formulas is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

3B Medical

3B Medical, Inc. Focused on innovative solutions in sleep therapy, with an emphasis on improving patient compliance with design focused on patient comfort. NEW! Introducing iCode for Android & iPhone. (For use with all RESmart CPAP & Auto-CPAP mod...

GENACTICS

GENACTICS is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.